Table of contents

Original research

• Antimalarial stocking decisions among medicine retailers in Ghana: implications for quality management and control of malaria (21 September, 2023)

  Adams Osman, Fiifi Amoako Johnson, Simon Mariwah, Daniel Amoako-Sakyi, Samuel Asiedu Owusu, Martins Ekor, Heather Hamill, Kate Hampshire
• Antimalarial procurement in private-sector pharmaceutical outlets: decision-making complexities and implications for medicine quality in Tanzania (10 September, 2023)

  Gerry Mshana, Tubeti Mayebe, Rebecca Balira, Heather Hamill, Kate Hampshire
• Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa (2 February, 2023)

  Zuzana Kusynová, Youssra Bais, Hendrika A van den Ham, Aukje K Mantel-Teeuwisse, Gisele Etame-Loe, Eliangiringa Kaale, Serigne Omar Sarr, Fatima Guiet-Mati, Pernette Bourdillon-Esteve
• Socioecological factors linked with pharmaceutical incentive-driven prescribing in Pakistan (2 February, 2023)

  Muhammad Naveed Noor, Afifah Rahman-Shepherd, Amna Rehana Siddiqui, Wafa Aftab, Sadia Shakoor, Rumina Hasan, Mishal Khan
• Why falsified medicines reach patients: an analysis of political and economic factors in Romania (2 February, 2023)

  Adina-Loredana Nistor, Elizabeth Pisani, Maarten Olivier Kok
• Implementing pharmaceutical track-and-trace systems: a realist review (28 May, 2021)

  Joeke Kootstra, Tineke Kleinhout-Vliek
• Monitoring, reporting and regulating medicine quality: tensions between theory and practice in Tanzania (28 May, 2021)

  Heather Hamill, Elizabeth David-Barrett, Joseph Rogathe Mwanga, Gerry Mshana, Kate Hampshire
• Challenges in maintaining medicine quality while aiming for universal health coverage: a qualitative analysis from Indonesia (28 May, 2021)

  Amalia Hasnida, Maarten Olivier Kok, Elizabeth Pisani